Literature DB >> 27262647

The Clinical Significance of Lumbosacral Transitional Vertebrae on the Surgical Outcomes of Lumbar Discectomy: A Retrospective Cohort Study of Young Adults.

Sang-Soak Ahn1, Dong-Kyu Chin2, Sang-Hyeon Kim3, Dong-Won Kim3, Byung-Hun Lee4, Min-Geun Ku5.   

Abstract

OBJECTIVE: To evaluate whether the presence of lumbosacral transitional vertebrae (LSTV) affects the clinical outcomes of microdiscectomy (MD) in young adults with lumbar disc herniation.
METHODS: We retrospectively included 398 patients who were followed-up for at least 2 years after MD for lumbar disc herniation at L4/5 (disc above the LSTV). The patients were divided into 2 groups. Group A was made up of 31 patients in whom LSTV was detected. Group B, in contrast, was made up of 35 patients in whom LSTV was not detected. The LSTV were classified using plain radiographs and three-dimensional computed tomography by Castellvi et al. The primary outcome measure was pain intensity at each follow-up visit assessed with visual analog scale for back and leg. Secondary outcome measures included the Oswestry Disability Index, a 12-item short-form health survey for quality of life, complications, and recurrence rate.
RESULTS: After surgery, the visual analog scale scores for the back and leg decreased significantly in both groups. However, the back pain intensity in group A worsened at 12 and 24 months postoperatively. The Oswestry Disability Index scores and 12-item short-form health survey (both mental and physical) worsened at 12 and 24 months postoperatively in group A. Two cases of reherniation (6.5 %) were observed in group A, who required reoperation.
CONCLUSIONS: LSTV can limit a patient's clinical improvement after MD with regard to pain intensity and recurrence. Caution must be taken when a patient is scheduled to undergo surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disc herniation; Discectomy; Lumbar spine; Lumbosacral transitional vertebrae fusion

Mesh:

Year:  2016        PMID: 27262647     DOI: 10.1016/j.wneu.2016.05.073

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

Review 1.  A review of lumbosacral transitional vertebrae and associated vertebral numeration.

Authors:  Jayson Lian; Nicole Levine; Woojin Cho
Journal:  Eur Spine J       Date:  2018-03-21       Impact factor: 3.134

2.  Sacral Dysmorphism and Lumbosacral Transitional Vertebrae (LSTV) Review.

Authors:  David M Matson; Lauren M Maccormick; Jonathan N Sembrano; David W Polly
Journal:  Int J Spine Surg       Date:  2020-02-10

3.  Prevalence of Bertolotti's Syndrome in Lumbosacral Surgery Procedures.

Authors:  Ahmed Ashour; Ahmed Hassan; Mohamed Aly; Mahmoud Am Nafady
Journal:  Cureus       Date:  2022-06-26

4.  Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5-S1 disc herniation: preliminary clinical outcomes.

Authors:  Jinlong Liu; Junlong Wu; Honglei Zhang; Rui Zuo; Jiabin Liu; Chao Zhang
Journal:  J Orthop Surg Res       Date:  2021-06-22       Impact factor: 2.359

5.  Lumbosacral Transitional Vertebrae in Adolescents: Effects on the Short-Term Outcomes of Percutaneous Endoscopic Lumbar Discectomy.

Authors:  Yong Huang; Lu Mao; Hang Shi; Guanrui Ren; Lei Zhu; Rui Zhang; Zhengming Shan; Xiaotao Wu
Journal:  Biomed Res Int       Date:  2021-07-12       Impact factor: 3.411

6.  Double Crush of L5 Spinal Nerve Root due to L4/5 Lateral Recess Stenosis and Bony Spur Formation of Lumbosacral Transitional Vertebra Pseudoarticulation: A Case Report and Review.

Authors:  Motoyuki Iwasaki; Masahiko Akiyama; Izumi Koyanagi; Yoshimasa Niiya; Tatsuo Ihara; Kiyohiro Houkin
Journal:  NMC Case Rep J       Date:  2017-09-15

7.  Short-term clinical efficacy of percutaneous transforaminal endoscopic discectomy in treating young patients with lumbar disc herniation.

Authors:  You-Long Zhou; Gang Chen; Dao-Chi Bi; Xing Chen
Journal:  J Orthop Surg Res       Date:  2018-03-20       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.